Skip to content
OpenCapital
Get started

Sionna Therapeutics, Inc. SION Q4 2024 Annual earnings

Reported March 20, 2025 · Before market open

EPS-$3.38Miss by $2.81
EPS estimate-$0.57

Next report

Aug 10, 2026 (In 1 week)
EPS estimate-$0.64

Financials

Q4 2024

Income statement

See full
Operating income-$18.1M—
Net income-$15.8M—
EPS (diluted)-$3.18—

Balance sheet

See full
Cash & equivalents$38.8M-1.9%
Total debt$9.7M—
Total equity-$163.7M-42.5%
Total assets$185.8M—

Cash flow

See full
Operating cash flow-$11.8M—
CapEx$27.0K—
Free cash flow-$11.8M—

Versus estimates

Diluted EPS

Q1 2026-$0.60Miss by $0.08Q4 2025-$0.46Beat by $0.08Q3 2025-$0.46Beat by $0.06Q2 2025-$0.41Beat by $0.27Q1 2025-$0.62Miss by $0.17
Q4 2024-$3.38Miss by $2.81

Ask the moment Sionna Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Sionna Therapeutics, Inc. report Q4 2024 earnings?
Sionna Therapeutics, Inc. (SION) reported Q4 2024 earnings on March 20, 2025 before market open.
What were Sionna Therapeutics, Inc.'s Q4 2024 revenue and EPS?
Sionna Therapeutics, Inc. reported eps of $-3.38 for Q4 2024.
Did Sionna Therapeutics, Inc. beat estimates in Q4 2024?
EPS missed the consensus estimate of $-0.57 by $2.81.
Where can I find Sionna Therapeutics, Inc.'s Q4 2024 SEC filings?
You can read the 10-K periodic report (0002036042-25-000005) directly on SEC EDGAR. The filing index links above go to sec.gov.